They drive NKs exhaustion and facilitate tumor immune escape by depleting activation factors like IL-2, releasing immunosuppressive molecules such as TGF-β and IL-10, and activating inhibitory receptors on NK cells, including PD-1 and TIGIT. The gene discussed is IL10; the disease is neoplasm.